Abstract
The United States is in the midst of ongoing opioid epidemic that is in large part, iatrogenic, meaning that it is associated with overprescribing of opioid analgesics by health care providers (Nelson et al., JAMA 314:1453–1454, 2015). Simultaneously, there is increasing prescribing of benzodiazepines and together, the increasing availability of these medications in American homes is adversely affecting all age groups, including adolescents (i.e., ages 12–21 years old) (Bachhuber et al., American Journal of Public Health 106:686–688, 2016). This chapter will review terminology including the pharmacological effects on persons using these substances, how effects change over time and characteristic withdrawal syndromes, epidemiology of adolescent opioid and benzodiazepine misuse, use disorder, treatment admissions, and associated morbidity such as overdose. Relevant risk factors will be reviewed followed by discussion of effective preventative, harm reduction and treatment approaches. Along the way, we will discuss common myths and misconceptions about prescription opioids and benzodiazepines, and heroin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association (APA). (2013). Desk reference to the diagnostic criteria from DSM-5. Washington, DC: American Psychiatric Publishing.
Bachhuber, M. A., Hennessy, S., Cunningham, C. O., & Starrels, J. L. (2016). Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013. American Journal of Public Health, 106(4), 686–688. https://doi.org/10.2105/AJPH.2016.303061
Bagley, S. M., Hadland, S. E., Carney, B. L., & Saitz, R. (2017). Addressing stigma in medication treatment of adolescents with opioid use disorder. Journal of Addiction Medicine, 11(6), 415–416. https://doi.org/10.1097/ADM.0000000000000348
Bell, J., & Mutch, C. (2006). Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: A file review. Drug Alcohol Review, 25(2), 167–171. https://doi.org/10.1080/09595230500537670
Black, K. I., Stephens, C., Haber, P. S., & Lintzeris, N. (2012). Unplanned pregnancy and contraceptive use in women attending drug treatment services. Australian and New Zealand Journal of Obstetrics and Gynaecology, 52(2), 146–150. https://doi.org/10.1111/j.1479-828X.2012.01413.x
Boyd, C. J., Austic, E., Epstein-Ngo, Q., Veliz, P. T., & McCabe, S. E. (2015). A prospective study of adolescents’ nonmedical use of anxiolytic and sleep medication. Psychology of Addictive Behaviors, 29(1), 184–191. https://doi.org/10.1037/adb0000026
Boyd, C. J., McCabe, S. E., Cranford, J. A., & Young, A. (2007). Prescription drug abuse and diversion among adolescents in a southeast Michigan school district. Archives of Pediatrics and Adolescent Medicine, 161(3), 276–281. https://doi.org/10.1001/archpedi.161.3.276
Centers for Disease Control and Prevention. (2015). National notifiable diseases surveillance system. Surveillance for viral hepatitis—United States 2015. Retrieved July 11, 2017, from https://www.cdc.gov/hepatitis/statistics/2015surveillance/index.htm.
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry, 71(7), 821–826. https://doi.org/10.1001/jamapsychiatry.2014.366
Cole, J. B., & Nelson, L. S. (2017). Controversies and carfentanil: We have much to learn about the present state of opioid poisoning. American Journal of Emergency Medicine, 35(11), 1743–1745. https://doi.org/10.1016/j.ajem.2017.08.045
Committee on Substance Use & Prevention. (2016). Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics, 138(3), 1–6. https://doi.org/10.1542/peds.2016-1893
Connery, H. S., Albright, B. B., & Rodolico, J. M. (2014). Adolescent substance use and unplanned pregnancy: Strategies for risk reduction. Obstetrics and Gynecology Clinics of North America, 41(2), 191–203. https://doi.org/10.1016/j.ogc.2014.02.011
Cotto, J. H., Davis, E., Dowling, G. J., Elcano, J. C., Staton, A. B., & Weiss, S. R. (2010). Gender effects on drug use, abuse, and dependence: A special analysis of results from the National Survey on Drug Use and Health. Gender Medicine, 7(5), 402–413. https://doi.org/10.1016/j.genm.2010.09.004
Curran, H. V. (1986). Tranquillising memories: A review of the effects of benzodiazepines on human memory. Biological Psychology, 23(2), 179–213.
Curran, H. V. (1991). Benzodiazepines, memory and mood: A review. Psychopharmacology, 105(1), 1–8.
Curtin, S. C., Tejada-Vera, B., & Warner, M. (2017). Drug overdose deaths among adolescents aged 15–19 in the United States: 1999–2015. NCHS data brief, no. 282. Hyattsville, MD: National Center for Health Statistics.
Edlund, M. J., Forman-Hoffman, V. L., Winder, C. R., Heller, D. C., Kroutil, L. A., Lipari, R. N., & Colpe, L. J. (2015). Opioid abuse and depression in adolescents: Results from the National Survey on Drug Use and Health. Drug and Alcohol Dependence, 152(2015), 131–138. https://doi.org/10.1016/j.drugalcdep.2015.04.010
Fernandes, R. M., Cary, M., Duarte, G., Jesus, G., Alarcao, J., Torre, C., . . . Carneiro, A. V. (2017). Effectiveness of needle and syringe programmes in people who inject drugs – An overview of systematic reviews. BMC Public Health, 17(1), 309. doi:https://doi.org/10.1186/s12889-017-4210-2
Fishman, M. J., Winstanley, E. L., Curran, E., Garrett, S., & Subramaniam, G. (2010). Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: Preliminary case-series and feasibility. Addiction, 105(9), 1669–1676. https://doi.org/10.1111/j.1360-0443.2010.03015.x
Frieden, T. R., & Houry, D. (2016). Reducing the risks of relief—The CDC opioid-prescribing guideline. New England Journal of Medicine, 374(16), 1501–1504. https://doi.org/10.1056/NEJMp1515917
Gaither, J. R., Leventhal, J. M., Ryan, S. A., & Camenga, D. R. (2016). National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatrics, 170(12), 1195–1201. https://doi.org/10.1001/jamapediatrics.2016.2154
Godley, M. D., Passetti, L. L., Subramaniam, G. A., Funk, R. R., Smith, J. E., & Meyers, R. J. (2017). Adolescent Community Reinforcement Approach implementation and treatment outcomes for youth with opioid problem use. Drug and Alcohol Dependence, 174, 9–16. https://doi.org/10.1016/j.drugalcdep.2016.12.029
Gowing, L., Farrell, M., Ali, R., & White, J. M. (2016). Alpha(2)-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews, (5), CD002024. https://doi.org/10.1002/14651858.CD002024.pub5 Hoboken, NJ: John Wiley & Sons, Inc.
Hopfer, C. J., Khuri, E., Crowley, T. J., & Hooks, S. (2002). Adolescent heroin use: A review of the descriptive and treatment literature. Journal of Substance Abuse Treatment, 23(3), 231–237.
Johnston, L. D., O’Malley, P. M., Miech, R. A., Bachman, J. G., & Schulenberg, J. E. (2016). Monitoring the Future national survey results on drug use, 1975–2015: Overview, key findings on adolescent drug use. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
Jones, C. M., & McAninch, J. K. (2015). Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. American Journal of Preventive Medicine, 49(4), 493–501. https://doi.org/10.1016/j.amepre.2015.03.040
Kann, L., McManus, T., Harris, W. A., Shanklin, S. L., Flint, K. H., Hawkins, J., … Zaza, S. (2016). Youth risk behavior surveillance – United States, 2015. MMWR Surveillance Summaries, 65(6), 1–174. https://doi.org/10.15585/mmwr.ss6506a1
Kerensky, T., & Walley, A. Y. (2017). Opioid overdose prevention and naloxone rescue kits: What we know and what we don’t know. Addiction Science & Clinical Practice, 12(1), 1–7. https://doi.org/10.1186/s13722-016-0068-3
Larance, B., Degenhardt, L., Lintzeris, N., Winstock, A., & Mattick, R. (2011). Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Review, 30(3), 236–245. https://doi.org/10.1111/j.1465-3362.2010.00283.x
Marsch, L. A., Bickel, W. K., Badger, G. J., Stothart, M. E., Quesnel, K. J., Stanger, C., & Brooklyn, J. (2005). Comparison of pharmacological treatments for opioid-dependent adolescents: A randomized controlled trial. Archives of General Psychiatry, 62(10), 1157–1164.
Marsch, L. A., Moore, S. K., Borodovsky, J. T., Solhkhah, R., Badger, G. J., Semino, S., … Ducat, E. (2016). A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults. Addiction, 111(8), 1406–1415. https://doi.org/10.1111/add.13363
McCabe, S. E., Veliz, P., Wilens, T. E., & Schulenberg, J. E. (2017). Adolescents’ prescription stimulant use and adult functional outcomes: A national prospective study. Journal of the American Academy of Child & Adolescent Psychiatry, 56(3), 226–233.e4. https://doi.org/10.1016/j.jaac.2016.12.008
McCabe, S. E., & West, B. T. (2014). Medical and nonmedical use of prescription benzodiazepine anxiolytics among U.S. high school seniors. Addictive Behaviors, 39(5), 959–964. https://doi.org/10.1016/j.addbeh.2014.01.009
McCabe, S. E., West, B. T., Teter, C. J., Ross-Durow, P., Young, A., & Boyd, C. J. (2011). Characteristics associated with the diversion of controlled medications among adolescents. Drug and Alcohol Dependence, 118(2-3), 452–458. https://doi.org/10.1016/j.drugalcdep.2011.05.004
McKim, W. (1986). Chapter 8: The benzodiazepines drugs and behavior: An introduction to behavioral pharmacology. Englewood Cliffs, NJ: Prentice Hall.
Miech, R., Johnston, L., O’Malley, P. M., Keyes, K. M., & Heard, K. (2015). Prescription opioids in adolescence and future opioid misuse. Pediatrics, 136(5), e1169–e1177. https://doi.org/10.1542/peds.2015-1364
Miech, R. A., Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2015). Monitoring the future national survey results on drug use, 1975–2014: Vol. I. Secondary school students. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
National Institute on Drug Abuse (NIDA). (2014). Principles of adolescent substance use disorder treatment: A research-based guide. Retrieved from https://www.drugabuse.gov/publications/principles-adolescent-substance-use-disorder-treatment-research-based-guide
Nelson, L. S., Juurlink, D. N., & Perrone, J. (2015). Addressing the opioid epidemic. JAMA, 314(14), 1453–1454. https://doi.org/10.1001/jama.2015.12397
O’Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017). Deaths involving fentanyl, fentanyl analogs, and U-47700 – 10 States, July–December 2016. Morbidity Mortality Weekly Report (MMWR), 66(43), 1197–1202. https://doi.org/10.15585/mmwr.mm6643e1
Palamar, J. J., Shearston, J. A., Dawson, E. W., Mateu-Gelabert, P., & Ompad, D. C. (2016). Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors. Drug and Alcohol Dependence, 158, 132–138. https://doi.org/10.1016/j.drugalcdep.2015.11.005
Rickert, V. I., Wiemann, C. M., & Berenson, A. B. (2000). Flunitrazepam: More than a date rape drug. Journal of Pediatric & Adolescent Gynecology, 13(1), 37–42.
Rigg, K. K., & Ford, J. A. (2014). The misuse of benzodiazepines among adolescents: Psychosocial risk factors in a national sample. Drug and Alcohol Dependence, 137, 137–142. https://doi.org/10.1016/j.drugalcdep.2014.01.026
Ross-Durow, P. L., McCabe, S. E., & Boyd, C. J. (2013). Adolescents’ access to their own prescription medications in the home. Journal of Adolescent Health, 53(2), 260–264. https://doi.org/10.1016/j.jadohealth.2013.02.012
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016). Increases in drug and opioid-involved overdose deaths – United States, 2010–2015. Morbidity Mortality Weekly Report (MMWR), 65(5051), 1445–1452. https://doi.org/10.15585/mmwr.mm655051e1
Schepis, T. S., & Krishnan-Sarin, S. (2009). Sources of prescriptions for misuse by adolescents: Differences in sex, ethnicity, and severity of misuse in a population-based study. Journal of the American Academy of Child & Adolescent Psychiatry, 48(8), 828–836. https://doi.org/10.1097/CHI.0b013e3181a8130d
Schuckit, M. A. (2016). Treatment of opioid-use disorders. New England Journal of Medicine, 375(16), 1596–1597. https://doi.org/10.1056/NEJMc1610830
Schuman-Olivier, Z., Claire Greene, M., Bergman, B. G., & Kelly, J. F. (2014). Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder. Drug and Alcohol Dependence, 144, 178–185. https://doi.org/10.1016/j.drugalcdep.2014.09.009
Schwartz, R. H., Milteer, R., & LeBeau, M. A. (2000). Drug-facilitated sexual assault (‘date rape’). Southern Medical Journal, 93(6), 558–561.
Strathdee, S. A., & Beyrer, C. (2015). Threading the needle—How to stop the HIV outbreak in rural Indiana. New England Journal of Medicine, 373(5), 397–399. https://doi.org/10.1056/NEJMp1507252
Subramaniam, G. A., & Stitzer, M. A. (2009). Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder. Drug and Alcohol Dependence, 101(1–2), 13–19. https://doi.org/10.1016/j.drugalcdep.2008.10.015
Substance Abuse and Mental Health Services Administration (SAMHSA). (2013). SAMHSA Opioid Overdose Prevention Toolkit. (HHS Publication No. SMA 13-4742). Rockville, MD: Substance Abuse and Mental Health Services Administration.
Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality. (2016a). Key substance use and mental health indicators in the United States: Results from the 2015 national survey on drug use and health (HHS Publication No. SMA 16-4984, NSDUH Series H-51). Retrieved from July 3, 2017, http://www.samhsa.gov/data.
Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality. (2016b). 2015 National survey on drug use and health: Detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration.
Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality. (2017). Treatment Episode Data Set (TEDS): 2005–2015. National admissions to substance abuse treatment services. BHSIS Series S-91 (HHS Publication No. SMA 17-5037). Rockville, MD: Substance Abuse and Mental Health Services Administration.
Tenore, P. L. (2010). Advanced urine toxicology testing. Journal of Addictive Diseases, 29(4), 436–448. 927630617 [pii]. https://doi.org/10.1080/10550887.2010.509277
U.S. Department of Health & Human Services (USDHHS), Office of the Surgeon General. (2016). Facing addiction in America: The Surgeon General’s report on alcohol, drugs, and health. Washington, DC: HHS.
Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine, 374(4), 363–371. https://doi.org/10.1056/NEJMra1511480
Wakeman, S. E., & Rich, J. D. (2018). Barriers to medications for addiction treatment: How stigma kills. Substance Use & Misuse, 53(2), 330–333. https://doi.org/10.1080/10826084.2017.1363238
Weaver, M. F. (2015). Prescription sedative misuse and abuse. Yale Journal of Biology and Medicine, 88(3), 247–256.
Welham, G. C., Mount, J. K., & Gilson, A. M. (2015). Type and frequency of opioid pain medications returned for disposal. Drugs Real World Outcomes, 2(2), 129–135. https://doi.org/10.1007/s40801-015-0019-4
Woody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., … Fudala, P. (2008). Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial. JAMA, 300(17), 2003–2011. https://doi.org/10.1001/jama.2008.574
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Lofwall, M.R., Yule, A.M. (2018). The Treatment and Prevention of Adolescent Opioid and Prescription Misuse and Abuse. In: Leukefeld, C., Gullotta, T. (eds) Adolescent Substance Abuse. Issues in Children's and Families' Lives. Springer, Cham. https://doi.org/10.1007/978-3-319-90611-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-90611-9_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90610-2
Online ISBN: 978-3-319-90611-9
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)